Rigel Pharmaceuticals | RIGL - EPS Earnings Per Share


Rigel Pharmaceuticals reported $0.7 in EPS Earnings Per Share for its fiscal quarter ending in September of 2024.





Eps Change Date
Agenus USD -0.3 0.84 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Celldex Therapeutics USD -1.22 0.21 Dec/2025
Daiichi Sankyo JPY 46.79 22.27 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Intrexon USD -0.1 0.03 Jun/2024
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
Ligand Pharmaceuticals USD 2.02 1.07 Dec/2025
MacroGenics USD -0.22 0.49 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Veracyte USD 0.53 0.02 Dec/2025